Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP2 inhibits Ubiquitin. 3 / 3

| 3

➶

reach

"Moreover, USP2 directly interacts with cyclin D1 and promotes its stabilization by antagonizing ubiquitin dependent degradation."

25972356

➶

reach

"The ubiquitin dependent proteolysis of cyclin D1 is antagonized by the deubiquitinating enzyme USP2, thus increasing cyclin D1 half-life."

30853938

➶

reach

"USP2 directly interacts with cyclin D1 and promotes its stabilization by antagonizing ubiquitin dependent degradation."

19917254

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP2 inhibits Ubiquitin. 3 / 3

Our Sources:

Databases

Reading